Vht stock price at $274

At $274.90, VHT stock price reflects stable investor sentiment toward healthcare. Earnings forecasts for the sector’s constituents have largely exceeded consensus, underpinning ETF valuation. Volpara Health Technologies is bordering on breakeven, according to the 2 Australian Healthcare Services analysts. They expect the company to post a final loss in 2024, before turning a profit of NZ$1.2m in 2025. Therefore, the company is expected to breakeven roughly 2 years from now. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 100%, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. Effective February 1, 2025, the expense ratio for VGT was reduced from 0.10% to 0.09%. While this reduction seems small, it can have a major impact on net returns for long-term investors. Overall, the VGT ETF has $87.36 billion in assets under management (AUM). Additionally, it has returned 20% in the past six months . This stability appeals to portfolios seeking consistent dividend yield and sector diversification.